Frequency of JAK2 V617F mutation in patients with Philadelphia positive Chronic Myeloid Leukemia in Pakistan

Authors

  • Najia Tabassum Mahfooz Baqai Medical University
  • Rubina Ghani Baqai Medical University
  • Mohammed Saboor Baqai Medical University
  • Moinuddin Moinuddin Baqai Medical University

DOI:

https://doi.org/10.12669/pjms.301.3906

Keywords:

Chronic myeloid leukemia, Philadelphia chromosome, BCR-ABL, JAK2 V617F mutation, JAK-STAT pathway.

Abstract

Background and Objective: Co-existence of myeloproliferative disorders (MPD) and Janus associated kinase 2 mutation (JAK2 V617F) is a well-established fact. Only few case reports are available showing presence of JAK2 V617F mutation in chronic myeloid leukemia (CML). Purpose of this study was to determine the frequency of JAK2 V617F mutation in Philadelphia Chromosome positive (Ph +) CML patients in Pakistan.

Methods: The study was conducted from August 2009 to July 2010 at Civil Hospital and Baqai Institute of Hematology (BIH) Karachi. Blood samples from 25 patients with CML were collected. Multiplex reverse transcription polymerase chain reaction (RT-PCR) was performed for Breakpoint Cluster Region

Author Biographies

Najia Tabassum Mahfooz, Baqai Medical University

Baqai Institute of Heamatology. Senior Instructor

Rubina Ghani, Baqai Medical University

Department of Biochemistry, Associate Professor

Mohammed Saboor, Baqai Medical University

Baqai Institute of Heamatology, Assistant Professor

Moinuddin Moinuddin, Baqai Medical University

Professor of Hematology, Dean (Faculty of Medicine and Dentistry)  and Director Institute of Hematology,

Downloads

Published

2014-01-10

How to Cite

Mahfooz, N. T., Ghani, R., Saboor, M., & Moinuddin, M. (2014). Frequency of JAK2 V617F mutation in patients with Philadelphia positive Chronic Myeloid Leukemia in Pakistan. Pakistan Journal of Medical Sciences, 30(1). https://doi.org/10.12669/pjms.301.3906